Application of Artificial Intelligence Modeling Technology Based on Fluid Biopsy to Diagnose Alzheimer’s Disease
Background: There are no obvious clinical signs and symptoms in the early stages of Alzheimer’s disease (AD), and most patients usually have mild cognitive impairment (MCI) before diagnosis. Therefore, early diagnosis of AD is very critical. This paper mainly discusses the blood biomarkers of AD pat...
Saved in:
Main Authors: | Yuan Sh, Benliang Liu, Jianhu Zhang, Ying Zhou, Zhiyuan Hu, Xiuli Zhang |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/39de30a2fedb48b8bac7173c6e7dc2a8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deterioro cognitivo leve y enfermedad de Alzheimer inicial en adultos mayores
by: Donoso,Archibaldo, et al.
Published: (2001) -
Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients
by: Zhang N, et al.
Published: (2018) -
Plasma Glutathione Levels Decreased with Cognitive Decline among People with Mild Cognitive Impairment (MCI): A Two-Year Prospective Study
by: Chieh-Hsin Lin, et al.
Published: (2021) -
Association of Clusterin Levels in Cerebrospinal Fluid with Synaptic Degeneration Across the Alzheimer’s Disease Continuum
by: Wang J, et al.
Published: (2020) -
The Potential of Naturalistic Eye Movement Tasks in the Diagnosis of Alzheimer’s Disease: A Review
by: Megan Rose Readman, et al.
Published: (2021)